biosensor
essenti
compos
biolog
recognit
element
bioreceptor
interact
analyt
respond
manner
regist
transduc
bioreceptor
crucial
compon
function
impart
select
sensor
respond
particular
analyt
biomolecul
interest
henc
avoid
interfer
substanc
transduc
convert
microbi
biorecognit
event
electr
signal
detect
use
electrochem
optic
piezoelectr
platform
biosensor
specif
target
nucleic
acid
hybrid
call
genosensor
genosensor
use
direct
ondemand
realtim
detect
discrimin
microbi
pathogen
clinic
specimen
malamud
colleagu
develop
group
genosensorbas
assay
detect
microbi
pathogen
oral
specimen
use
diagnosi
multipl
infecti
diseas
piezoelectr
dna
biosensor
directli
detect
hepat
b
viru
develop
base
masstransduc
function
quartz
crystal
microbal
nucleic
acid
hybrid
anoth
hybridizationbas
amperometr
biosensor
use
osmium
electrochem
indic
use
detect
confirm
virusspecif
pcr
product
gener
semidispos
fluoresc
biosensor
develop
directli
detect
dengu
viru
rna
hybridizationbas
genosensor
gold
film
coupl
enzymat
electrochem
detect
design
detect
sarscov
rna
fluoresc
semiconductor
nanocryst
known
quantum
dot
qdot
colloid
particl
consist
semiconductor
core
high
band
gap
materi
shell
typic
outer
coat
layer
coresizedepend
photoluminesc
narrow
emiss
bandwidth
span
visibl
spectrum
broad
adsorpt
spectra
allow
simultan
excit
mix
qdot
popul
singl
wavelength
qdot
also
exhibit
sever
uniqu
featur
high
quantum
yield
high
resist
photodegrad
better
nearinfrar
emiss
new
gener
qdot
farreach
potenti
studi
intracellular
process
broad
field
includ
diagnost
highsensit
bacteri
detect
use
biotintag
phage
quantumdot
nanocomplex
describ
provid
specif
limit
detect
bacteri
cellsml
hour
beadbas
microfluid
devic
develop
achiev
elisa
qdot
label
fluorophor
viru
detect
three
group
report
use
qdot
conjug
specif
monoclon
antibodi
detect
identifi
presenc
respiratori
syncyti
viru
rsv
realtim
manner
impli
qdot
may
provid
method
earli
rapid
detect
rsv
infect
addit
microbi
pathogen
antigen
detect
posit
charg
compact
qdotdna
complex
describ
detect
flua
viru
nucleic
acid
present
concentr
low
nmol
simultan
excit
sever
emissiontun
qdot
popul
combin
pool
differenti
label
probe
multiplex
target
analysi
qdotbas
techniqu
develop
detect
panel
respiratori
virus
produc
effici
assay
requir
smaller
quantiti
target
nucleic
acid
first
describ
notomi
colleagu
loopmedi
isotherm
amplif
lamp
simpl
rapid
specif
nucleic
acid
amplif
method
character
use
multipl
primer
specif
design
recogn
sever
distinct
region
target
gene
amplif
detect
target
gene
complet
singl
step
incub
mixtur
sampl
primer
dna
polymeras
strand
displac
activ
substrat
constant
temperatur
amplif
isotherm
lamp
requir
special
reagent
sophist
temperatur
control
devic
increas
turbid
reaction
mixtur
accord
product
precipit
correl
amount
dna
synthes
realtim
monitor
lamp
reaction
achiev
turbid
measur
detect
limit
one
two
copi
lamp
capabl
detect
presenc
pathogen
agent
earlier
pcr
gene
copi
number
low
lamp
success
appli
rapid
realtim
detect
sever
emerg
reemerg
human
pathogen
includ
west
nile
viru
dengu
viru
japanes
enceph
viru
monkey
pox
viru
rift
valley
viru
sarscov
chikungunya
viru
norovirus
poon
colleagu
describ
use
rtlamp
detect
flua
virus
cover
anoth
similar
rtlamp
assay
describ
recent
detect
flua
viru
subtyp
strain
flub
viru
strain
limit
detect
focusform
unit
per
ml
assay
complet
within
hour
provid
rapid
sensit
detect
two
onestep
rtlamp
assay
analyt
sensit
plaqueform
unit
pfu
per
reaction
develop
specif
detect
highli
pathogen
avian
flua
virus
valid
use
viral
strain
isol
past
year
clinic
specimen
rtlamp
assay
report
specif
detect
subtyp
avian
flu
viru
detect
limit
copi
per
reaction
lower
rtpcr
japan
lamp
assay
use
rapidli
subtyp
flua
viru
confirm
two
case
influenza
patient
return
thailand
addit
detect
type
flu
virus
subgroupabspecif
rtlamp
assay
develop
amplifi
rsv
improv
current
diagnost
method
rsv
infect
assay
valid
use
nasopharyng
aspir
children
respiratori
tract
infect
result
indic
rtlamp
sensit
viral
isol
antigen
test
rsv
detect
sever
lampbas
assay
report
rapid
detect
sarscov
advantag
rapid
amplif
simpl
oper
eas
detect
lampbas
assay
also
use
detect
respiratori
viral
pathogen
mump
measl
adenovirus
comparison
convent
rtpcr
rtlamp
assay
demonstr
enhanc
sensit
detect
limit
pfu
viru
case
recent
establish
netherland
multiplex
ligationdepend
probe
amplif
mlpa
make
use
ligat
pcr
invent
modifi
previous
describ
ligationdepend
pcr
assay
mlpa
platform
featur
greatli
reduc
probe
concentr
longer
hybrid
period
gener
condit
compat
multiplex
analysi
mlpa
probe
consist
pair
oligonucleotid
subject
ligat
hybrid
target
sequenc
analog
padlock
probe
see
later
discuss
one
oligonucleotid
consist
fluoresc
label
univers
forward
primer
bind
site
targetspecif
recognit
sequenc
end
wherea
oligonucleotid
consist
targetspecif
recognit
sequenc
end
nonspecif
stretch
dna
defin
length
stuffer
sequenc
univers
revers
primer
bind
site
end
mlpa
assay
divid
three
basic
step
anneal
probe
target
sequenc
ligat
probe
pcr
amplif
ligat
probe
use
univers
primer
multiplex
achiev
vari
length
stuffer
sequenc
uniqu
set
probe
use
assay
amplif
emerg
molecular
assay
product
detect
use
highresolut
electrophoret
techniqu
capillari
electrophoresi
claim
approach
allow
rel
quantif
mlpabas
techniqu
prove
suffici
sensit
reproduc
sequenc
specif
use
screen
human
dna
recent
studi
use
mlpa
assay
detect
identif
sever
pathogen
microorgan
includ
rapid
character
mycobacterium
tuberculosi
rel
quantif
target
bacteri
speci
oral
microbiota
reijan
colleagu
describ
mlpa
technologybas
respifind
assay
detect
respiratori
virus
simultan
one
reaction
case
mlpa
reaction
preced
preamplif
step
ensur
detect
rna
dna
virus
specif
sensit
individu
monoplex
realtim
rtpcr
assay
respifind
assay
show
satisfactori
specif
perfect
sensit
adenoviru
human
metapneumoviru
hmpv
flua
parainfluenza
viru
piv
type
rhinoviru
rhv
rsv
use
respifind
assay
result
increas
diagnost
yield
compar
cell
cultur
assay
extend
cover
four
addit
bacteri
pathogen
caus
respiratori
tract
infect
mycoplasma
pneumonia
chlamydophila
pneumonia
legionella
pneumophila
bordetella
pertussi
pcr
amplif
techniqu
use
arbitrari
primer
includ
arbitrarili
prime
ap
pcr
sequenceindepend
singleprim
amplif
sispa
randomli
amplifi
polymorph
dna
rapd
gener
base
pcr
amplif
random
dna
segment
short
primer
usual
singl
nucleotid
contain
arbitrari
nucleotid
sequenc
rapdbas
assay
increasingli
use
type
microorgan
especi
clinic
outbreak
rapdpcr
techniqu
seem
practic
effici
routin
use
highresolut
viral
divers
studi
provid
assemblag
comparison
fingerprint
probe
sequenc
inform
similar
techniqu
use
character
polymeras
gene
genom
termini
nipah
viru
avian
flu
viru
genom
sequenc
hand
appcr
sispabas
assay
mainli
use
discoveri
character
novel
noncultivat
virus
viral
pathogen
possess
conserv
univers
gene
rrna
gene
sispa
use
earli
random
pcr
amplif
strategi
amplifi
known
unknown
viral
gene
includ
hepat
c
viru
rotaviru
noroviru
appcr
techniqu
use
success
obtain
sequenc
inform
novel
hmpv
viru
cultur
wang
colleagu
use
similar
random
amplif
techniqu
conjunct
long
oligonucleotid
panvir
microarray
simultan
screen
detect
hundr
viral
pathogen
system
success
use
detect
human
strain
associ
respiratori
failur
identif
novel
gammaretroviru
patient
prostat
tumor
diagnosi
critic
respiratori
ill
caus
hmpv
identif
cardiovirus
relat
theiler
murin
encephalomyel
viru
human
infect
quan
colleagu
recent
report
use
similar
random
amplif
process
follow
comprehens
microarray
analysi
greenechipresp
detect
divers
respiratori
viral
pathogen
subtyp
flua
virus
modifi
sispa
incorpor
dnase
treatment
recent
use
discov
identifi
character
sever
novel
bovin
human
viral
pathogen
directli
clinic
sampl
technolog
use
character
common
epitop
enteroviru
env
identif
novel
human
coronaviru
detect
tt
viru
stool
sampl
collect
gastroenter
outbreak
discoveri
novel
uncultur
virus
specimen
collect
patient
present
fever
unknown
origin
although
pcr
amplif
use
arbitrari
primer
extrem
power
approach
screen
discoveri
new
noncultiv
viral
pathogen
directli
clinic
specimen
subsequ
identif
confirm
step
hinder
background
nonspecif
random
amplif
product
develop
thu
requir
optim
technolog
routin
diagnost
use
molecular
microbiolog
laboratori
multiplex
pcr
develop
use
numer
primer
within
singl
reaction
tube
amplifi
nucleic
acid
fragment
differ
target
multipl
set
highconcentr
primer
convent
multiplex
reaction
often
favor
primerdim
format
howev
result
nonspecif
amplif
meet
challeng
convent
multiplex
pcr
han
colleagu
develop
targetenrich
multiplex
tem
pcr
technolog
use
nest
genespecif
primer
extrem
low
concentr
enrich
specif
target
earli
pcr
cycl
reli
univers
forward
revers
superprim
high
unequ
concentr
achiev
exponenti
asymmetr
target
amplif
tempcr
amplif
report
detect
type
semiquantif
human
papillomavirus
detect
differenti
panel
respiratori
bacteri
pathogen
detect
differenti
antituberculosi
drug
resistancerel
mutat
determin
antibiot
resist
detect
toxinencod
gene
staphylococcu
aureu
screen
differenti
methicillinresist
aureu
vancomycinresist
enterococci
character
type
flua
includ
use
tem
technolog
resplex
ii
assay
develop
detect
flua
flub
rsv
hmpv
rhv
env
sarscov
singl
reaction
monoplex
rt
pcr
use
pathogen
detect
clinician
often
consid
possibl
presenc
pathogen
given
posit
result
multiplex
approach
offer
resplex
ii
system
enhanc
diagnosi
detect
respiratori
viral
etiolog
agent
case
presenc
unsuspect
appropri
test
consequ
order
clinician
recent
studi
brunstein
colleagu
reveal
use
resplex
ii
kit
cover
viral
pathogen
specimen
coinfect
two
three
differ
virus
low
level
crossreact
notic
use
assay
coinfect
medic
relev
effect
treatment
sever
respiratori
tract
infect
increasingli
requir
diagnosi
involv
pathogen
oppos
singlepathogen
report
origin
resplex
ii
system
detect
rna
virus
adenovirus
bocaviru
four
coronavirus
ad
recent
releas
new
version
resplex
ii
preliminari
data
indic
overal
sensit
specif
resplex
ii
compar
resplex
ii
panel
notabl
number
previous
neg
sampl
found
posit
one
newli
ad
bocaviru
coronaviru
target
john
brunstein
person
commun
factor
could
diminish
analyt
clinic
perform
resplex
ii
resplex
ii
potenti
falseposit
result
caus
carryov
pcr
product
use
luminex
platform
direct
amplicon
sequenc
provid
simpl
rapid
accur
mean
detect
identif
amplif
product
need
robust
highthroughput
method
replac
eleg
sanger
method
describ
year
ago
led
develop
sever
new
principl
ronaghi
colleagu
describ
pyrosequenc
techniqu
nongelbas
realtim
approach
sequenc
dna
monitor
dna
polymeras
activ
pyrosequenc
base
enzymat
inorgan
pyrophosph
releas
dna
polymeras
reaction
stoichiometr
amount
light
produc
proport
number
pyrophosph
molecul
gener
henc
number
incorpor
nucleotid
unincorpor
nucleotid
degrad
apyras
next
nucleotid
ad
way
sequenc
inform
interrog
region
gener
quantit
real
time
although
basic
approach
perform
pyrosequenc
remain
numer
commerci
system
use
wide
rapidli
identifi
infecti
agent
screen
antimicrobi
drug
resist
multiplex
pyrosequenc
involv
simultan
extens
sever
primer
hybrid
one
target
dna
templat
gain
broad
accept
field
cytogenet
pharmacogenet
medic
genet
applic
pyrosequenc
identif
character
respiratori
virus
focus
flua
base
pyrosequenc
technolog
rapid
highli
inform
diagnost
assay
report
detect
flu
virus
sequenc
critic
region
within
viru
develop
screen
method
high
volum
activ
realtim
rtpcr
pyrosequenc
assay
develop
combin
restrict
enzym
digest
direct
sequenc
screen
verifi
flu
infect
human
anoth
rtpcr
assay
subsequ
pyrosequenc
analysi
allow
rapid
highthroughput
costeffect
screen
subtyp
virus
clearli
discrimin
wildtyp
mutant
virus
studi
report
bright
colleagu
show
alarm
increas
incid
amantadineand
rimantadineresist
flua
virus
worldwid
pyrosequenc
techniqu
configur
cover
pair
region
proteinencod
gene
pyrosequenc
assay
capabl
expand
screen
amino
acid
chang
defin
avian
human
specif
pyrosequencingbas
assay
recent
design
detect
surveil
commonli
report
mutat
associ
resist
neuraminidas
inhibitor
adamantan
latter
detect
mutat
associ
resist
directli
clinic
specimen
thu
reduc
time
requir
test
avoid
select
novel
sequenc
variant
cell
cultur
addit
pyrosequencingbas
assay
report
character
quantif
type
subtyp
drugresist
profil
virus
one
uniqu
featur
pyrosequenc
theoret
adapt
analysi
genet
marker
allow
detect
multipl
known
unknown
mutat
singl
pyrosequenc
reaction
integr
highthroughput
pyrosequenc
instrument
becom
power
tool
whole
genom
sequenc
without
need
addit
equip
molecular
techniqu
standard
pcr
genom
sequenc
flx
sampl
prepar
sequenc
pipelin
pyrosequenc
gener
sequenc
content
quantit
made
pyrosequenc
primari
choic
quantifi
specif
mutat
eg
detect
drug
resistanceassoci
signatur
mix
genom
popul
pyrosequenc
byproduct
inhibit
sequenc
reaction
pyrosequenc
read
length
limit
less
base
pair
anoth
drawback
pyrosequencingbas
techniqu
includ
secondari
structur
format
affect
qualiti
result
particularli
gcrich
target
addit
may
difficult
determin
precis
number
nucleotid
homopolymer
region
base
peak
height
expect
pyrosequencingbas
diagnost
devic
soon
becom
avail
rapid
character
type
viral
pathogen
padlock
probe
origin
nilsson
colleagu
linear
oligonucleotid
design
two
end
segment
connect
linker
region
complementari
target
sequenc
hybrid
target
sequenc
two
probe
end
becom
juxtapos
join
dna
ligas
react
probe
detect
way
report
molecul
attach
linker
altern
amplifi
signal
obtain
circular
probe
roll
circl
amplif
padlock
probe
provid
mean
detect
quantif
larg
number
dna
rna
sequenc
highli
multiplex
genet
studi
applic
padlock
probe
detect
microbi
pathogen
recent
trend
molecular
diagnos
uniqu
padlock
probe
design
provid
benefit
speed
sensit
deriv
use
nucleic
acidbas
method
amount
inform
greatli
increas
extens
multiplex
inde
method
use
simultan
detect
type
ha
na
subtyp
avian
flu
viru
analysi
complet
within
approxim
hour
perform
singl
reaction
tube
help
decreas
risk
contamin
sequenti
addit
reagent
readout
perform
use
oligonucleotid
array
padlock
probe
combin
backend
microarray
technolog
develop
detect
footandmouth
diseas
vesicular
stomat
swine
vesicular
diseas
virus
besid
viral
pathogen
padlock
probebas
techniqu
rapidli
extend
recent
year
identif
character
bacteri
fungal
pathogen
addit
applic
padlock
probe
direct
target
detect
univers
primer
bind
site
introduc
probe
use
mlpa
see
previou
discuss
applic
microarray
detect
character
respiratori
virus
began
solid
array
first
respiratori
panvir
microarray
system
describ
incorpor
uniqu
oligonucleotid
probe
cover
approxim
viral
genom
sequenc
resequenc
microarray
develop
use
short
oligonucleotid
simultan
identif
respiratori
pathogen
speci
strain
level
anoth
comprehens
panmicrobi
microarray
greenechipresp
system
develop
detect
respiratori
virus
subtyp
identif
flua
virus
recent
develop
solid
microarray
system
detect
identif
panel
respiratori
virus
includ
infin
analyz
integr
molecular
diagnost
devic
incorpor
microarray
hybrid
electron
microarraybas
nanochip
taqman
low
densiti
array
card
use
realtim
pcr
assay
virus
bacteria
known
caus
pneumonia
dean
erdman
person
commun
filmarray
detect
differenti
viral
suspens
beadbas
liquid
xmap
microarray
develop
luminex
corp
essenti
threedimension
array
base
use
microscop
polystyren
bead
solid
support
flow
cytometri
bead
target
detect
robust
multiplex
detect
accomplish
use
differ
bead
set
base
fluoresc
system
enabl
multiplex
analyt
singl
reaction
use
small
sampl
volum
numer
studi
describ
use
xmap
technolog
detect
differenti
nucleic
acid
sequenc
microbi
pathogen
includ
enter
bacteria
virus
mycobacteria
fungi
protozoa
molecular
type
method
incorpor
suspens
array
report
character
type
flua
virus
includ
luminex
suspens
array
incorpor
sever
commerci
devic
detect
platform
support
laboratori
differenti
diagnosi
common
respiratori
viral
pathogen
includ
xtag
respiratori
viral
panel
luminex
molecular
diagnost
resplex
ii
assay
qiagen
multicodeplx
rvp
assay
eragen
bioscienc
suspens
array
system
exhibit
rapid
hybrid
kinet
flexibl
assay
design
format
rel
low
cost
made
practic
microarray
platform
clinic
diagnost
applic
user
care
determin
posit
fluoresc
threshold
viral
target
multiplex
userdefin
assay
valid
matrixassist
laser
desorptionion
timeofflight
malditof
mass
spectrometri
ms
wide
use
power
proteom
tool
rapid
high
resolut
provid
anoth
power
platform
detect
character
nucleic
acid
amplif
product
technolog
premis
capac
malditof
ms
discrimin
individu
pcr
product
contain
complex
amplicon
mixtur
accord
nucleotid
base
composit
deconvolut
algorithm
allow
base
composit
pcr
product
deduc
mass
spectrometr
measur
molecular
weight
complementari
natur
dna
lead
organ
identif
earli
studi
success
use
techniqu
directli
detect
amplif
product
pcr
ligas
chain
reaction
lcr
soon
malditof
ms
platform
link
pcr
amplif
genotyp
analysi
hepat
c
viru
human
papillomaviru
detect
human
herpesvirus
clinic
specimen
perform
use
malditof
ms
follow
multiplex
pcr
amplif
malditof
msbase
genotyp
assay
describ
monitor
develop
hepat
b
viru
polymeras
ymdd
mutant
genotyp
lamivudin
treatment
integr
system
ibi
biosensor
develop
coupl
broadrang
nucleic
acid
amplif
highperform
electrospray
ioniz
ms
basecomposit
analysi
system
enabl
identif
quantif
broad
set
pathogen
includ
known
bacteria
major
group
pathogen
fungi
major
famili
virus
caus
diseas
human
anim
along
detect
virul
factor
antibiot
resist
marker
system
use
rapid
identif
strain
type
respiratori
bacteri
pathogen
epidem
surveil
identif
genotyp
acinetobact
baumannii
strain
outbreak
associ
war
trauma
determin
quinolon
resist
acinetobact
speci
genotyp
campylobact
speci
rapid
genotyp
clonal
complex
assign
staphylococcu
aureu
isol
use
system
tabl
comparison
commerci
avail
multiplex
amplif
highthroughput
system
detect
identif
respiratori
virus
detect
ehrlichia
anaplasma
rickettsia
pathogen
directli
blood
specimen
diagnosi
tickborn
sepsi
manuscript
prepar
field
diagnost
virolog
strategi
success
led
inclus
sarscov
coronaviru
famili
furthermor
ibi
biosensor
system
use
rapid
inexpens
tool
global
surveil
emerg
flu
viru
genotyp
rapid
detect
molecular
serotyp
adenovirus
compar
summari
devic
present
tabl
rel
simplic
power
multiplex
capabl
afford
highthroughput
detect
make
platform
attract
screen
detect
panel
respiratori
virus
clinic
infecti
diseas
diagnost
although
essenti
avail
food
drug
administrationclear
product
critic
step
get
system
lessexperienc
diagnost
microbiolog
laboratori
open
postamplif
tube
subsequ
pipet
step
workflow
suspens
array
increas
risk
intraand
interrun
contamin
assay
care
attent
paid
contamin
control
measur
reestablish
dedic
postamplif
laboratori
space
realtim
pcr
era
simultan
test
possibl
pathogen
effici
mean
obtain
conclus
result
improv
etiolog
diagnosi
addit
assay
potenti
pathogen
may
yield
crucial
inform
regard
coinfect
secondari
infect
one
studi
netherland
indic
implement
multipl
molecular
assay
etiolog
diagnosi
lower
respiratori
tract
infect
increas
diagnost
yield
consider
yet
reduc
antibiot
use
cost
clinic
relev
cost
effect
simultan
multipathogen
detect
identif
strategi
merit
investig
author
thank
john
brunstein
david
ecker
dean
erdman
jiang
fan
mark
poritz
discuss
jame
chappel
charl
stratton
review
manuscript
